Know Cancer

or
forgot password

Randomized, Parallel Group, Clinical Trial Comparing Intravenous Iron Sucrose Versus Oral Ferrous Sulphate in the Treatment of Perioperative Iron Deficiency in Patients With Colo-Rectal Neoplasm and Iron Deficiency Anemia.


Phase 4
18 Years
N/A
Not Enrolling
Both
Colorectal Neoplasm, Iron Deficiency Anemia

Thank you

Trial Information

Randomized, Parallel Group, Clinical Trial Comparing Intravenous Iron Sucrose Versus Oral Ferrous Sulphate in the Treatment of Perioperative Iron Deficiency in Patients With Colo-Rectal Neoplasm and Iron Deficiency Anemia.


Most patients with colorectal neoplasm have iron deficiency, which can be triggered in the
pre-operative period by a decrease of iron intake and the bleeding in the site of neoplasm.

In the postoperative period, iron deficiency can be aggravated by surgical bleeding.

Iron plays a leading rol in haemoglobin production, cell mitosis and immune system. Animal
experimentation has shown that induced iron deficiency and mild anemia lead to postoperative
mortality and lactacidemia in a model of peritonitis.

Moreover, anemia is the main risk factor to require intra and postoperative blood
transfusions, and iron deficiency and anemia are associated to a larger number of
postoperative complications (infections and longer hospital stay).

Oral iron therapy is the standard treatment in patients with preoperative iron deficiency,
but iron levels inside red cells may not reach normality in time before surgery, and it can
not be resumed until the patient can start again oral feeding.

In these patients, any increase in preoperative haemoglobin decreases the risk to need a
blood transfusion during or after surgery.

This trial will compare standard oral iron and intravenous iron.


Inclusion Criteria:



- Non-recurrent colorectal neoplasm, surgically resectable

- Anemia

Exclusion Criteria:

- Severe renal impairment

- High anesthetic risk

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Preoperative variations in hemoglobin.

Principal Investigator

Pere Poch Martí, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Fundació Hospital-Asil de Granollers (Barcelona, Spain)

Authority:

Spain: Spanish Agency of Medicines

Study ID:

DM01VEN/4/03

NCT ID:

NCT00199277

Start Date:

Completion Date:

Related Keywords:

  • Colorectal Neoplasm
  • Iron Deficiency Anemia
  • Anemia
  • Neoplasms
  • Colorectal Neoplasms
  • Rectal Neoplasms
  • Deficiency Diseases
  • Anemia, Iron-Deficiency

Name

Location